Glenn Steele to Step Down as CEO of Geisinger Health System

By Admin
Share
Geisinger Health System has announced the search for a successor to CEO Dr. Glenn Steele. Steele will remain at Geisinger through the end of the system...

Geisinger Health System has announced the search for a successor to CEO Dr. Glenn Steele.

Steele will remain at Geisinger through the end of the system’s fiscal year in June 2015 while the system searches for a new CEO with the help of Spencer Stuart, an executive search consulting firm.

“This is a planned and expected process to ensure that we take the time necessary to identify Geisinger’s next leader,” William Alexander, board chair, said in a news release. “Dr. Steele has done an incredible job of leading and growing the health system, as well as expanding innovative healthcare services for Geisinger’s patients and members.”

Upon leaving his post as CEO next year, Steele will continue to serve as chairman of xG Health Solutions, an independently operated venture launched in 2013 by Geisinger, reported Modern Healthcare.  xG Health Solutions offers its clients consulting, interpretation and reporting of population health data analytics, patient- and population-focused care management and third party administration services.

Steele arrived at Geisinger in March 2001, previously working for the University of Chicago as a professor in the department of surgery, VP for medical affairs and dean of the division of biological sciences and the Pritzker School of Medicine.

Steele is a member of the Institute of Medicine and past chair of the American Board of Surgery. Serving on the editorial board of numerous medical journals, Steele’s investigations have focused on the cell biology of gastrointestinal cancer and pre-cancer.

According to its site, Geisinger serves more than 2.6 million residents throughout 44 counties in central and northeastern Pennsylvania. 

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma